Sugi Predict

Sugi Predict / Compounds / SCHEMBL565833

SCHEMBL565833

SCHEMBL565833

C=CCNc1ccc(C(C)(C)c2ccc(O)c(NCC=C)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ ESR1 P03372 3/20 0.40
▸ KLF10 Q13118 1/20 0.40
▸ MAPT P10636 1/20 0.38
▸ RORC P51449 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ HCAR3 P49019 1/20 0.33
▸ CACNA1B Q00975 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565866 0.93 ESR1 (0.46) CA12CA1CA2CA9ESR1
SCHEMBL566122 0.90 ESR1 (0.46) CA12CA1CA2CA9ESR1
SCHEMBL565156 0.89 CA12 (0.41) CA12CA1CA2CA9ESR1
SCHEMBL564549 0.89 ALDH1A1 (0.45) ESR1KLF10MAPTRORCALDH1A1
SCHEMBL565071 0.88 ESR1 (0.39) CA12CA1CA2CA9ESR1
SCHEMBL565964 0.84 ESR1 (0.43) ESR1KLF10RORCALDH1A1KDM4E
SCHEMBL5772260 0.83 CA1 (0.50) CA12CA1CA2CA9ESR1
SCHEMBL16641018 0.83 CA1 (0.50) CA12CA1CA2CA9ESR1
SCHEMBL565501 0.81 ESR1 (0.42) CA12CA1CA2CA9ESR1
SCHEMBL564785 0.79 ESR1 (0.46) CA12CA1CA2CA9ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 — — US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 — — US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 — — US disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 — — US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 — — US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 — — US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 CA12 4316/4885CA1 3199/4885CA2 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.